Aquablation Sales Representative - Japan at PROCEPT BioRobotics

Japan

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Devices, Healthcare, MedTechIndustries

Skills

Key technologies and capabilities for this role

Medical SalesTerritory ManagementSales ForecastingValue Proposition SellingSurgeon TrainingLead GenerationProduct LaunchSolution SellingHospital AdministrationUrology

Questions & Answers

Common questions about this position

Is this position remote?

Yes, this is a remote position.

What is the salary for this Aquablation Sales Representative role?

This information is not specified in the job description.

What skills or experience are required for this role?

This information is not specified in the job description.

What is the company culture like at PROCEPT BioRobotics?

PROCEPT BioRobotics is committed to revolutionizing BPH treatment through surgical robotics innovation, guided by their vision, mission, and values, with a strong focus on people and continuous career growth opportunities.

What makes a strong candidate for this sales representative position?

A strong candidate is a highly motivated individual focused on executing activities, exceeding sales targets, balancing tactical and strategic decision-making, and working effectively with clinicians, hospital staff, and internal teams.

PROCEPT BioRobotics

Develops robotic solutions for BPH treatment

About PROCEPT BioRobotics

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.

Redwood City, CaliforniaHeadquarters

2009Year Founded

$319.1MTotal Funding

IPOCompany Stage

Robotics & Automation, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Parental Leave

Paid Holidays

Wellness Program

Gym Membership

Risks

Competition from Intuitive Surgical and Medtronic may impact market share.

$175 million public stock offering could lead to shareholder dilution.

Reliance on AquaBeam System makes company vulnerable to technological failures.

Differentiation

AquaBeam Robotic System offers image-guided, minimally invasive urologic surgery.

Aquablation therapy provides effective outcomes regardless of prostate size or surgeon experience.

PROCEPT has over 100 peer-reviewed publications supporting Aquablation therapy's benefits.

Upsides

Increasing adoption of robotic-assisted surgeries boosts demand for AquaBeam System.

Global urology devices market projected to grow at 6.9% CAGR until 2030.

FDA's supportive regulatory environment favors innovative medical technologies like PROCEPT's.

Land your dream remote job 3x faster with AI

Try Jobo Free